To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Similar blood loss and lower cost with oral TXA vs. both IA TXA and IV TXA in total hip arthroplasty

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
May 2018

Similar blood loss and lower cost with oral TXA vs. both IA TXA and IV TXA in total hip arthroplasty

Vol: 7| Issue: 5| Number:5| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Oral vs Intravenous vs Topical Tranexamic Acid in Primary Hip Arthroplasty: A Prospective, Randomized, Double-Blind, Controlled Study

J Arthroplasty. 2018 Mar;33(3):786-793

Contributing Authors:
FX Pei ZK Zhou HY Wang D Wang ZY Luo K Zhou

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

180 patients scheduled for total hip arthroplasty were randomized to oral tranexamic acid, intravenous tranexamic acid, or intraarticular tranexamic acid. Results demonstrated no significant differences between the three groups in hemoglobin drop, total blood loss, or transfusion rate. Additionally, no patient in any of the groups developed DVT or PE. Cost analysis demonstrated significantly lower...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue